Education
About Us
Working with TipRanks
Follow Us
Zevra Therapeutics (ZVRA)
NASDAQ:ZVRA
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 106.47M | $ 23.61M | $ 27.46M | $ 10.16M | $ 28.65M |
| Gross Profit | $ 85.93M | $ 16.20M | $ 24.52M | $ 9.94M | $ 26.59M |
| Operating Income | $ -4.23M | $ -87.00M | $ -49.60M | $ -42.56M | $ 7.73M |
| EBITDA | $ -179.00K | $ -76.40M | $ -43.54M | $ -25.53M | $ -7.89M |
| Net Income | $ 83.23M | $ -105.51M | $ -46.05M | $ -26.77M | $ -8.55M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 62.41M | $ 69.50M | $ 67.74M | $ 82.85M | $ 112.35M |
| Total Assets | $ 284.73M | $ 178.13M | $ 172.33M | $ 115.34M | $ 132.94M |
| Total Debt | $ 63.21M | $ 60.30M | $ 43.77M | $ 18.78M | $ 1.61M |
| Net Debt | $ 800.00K | $ 26.51M | $ 716.00K | $ -46.69M | $ -110.74M |
| Total Liabilities | $ 130.07M | $ 138.46M | $ 110.46M | $ 40.22M | $ 5.82M |
| Stockholders' Equity | $ 154.66M | $ 39.67M | $ 61.86M | $ 75.12M | $ 127.12M |
| Cash Flow | |||||
| Free Cash Flow | $ -2.43M | $ -69.67M | $ -33.83M | $ -18.81M | $ 10.34M |
| Operating Cash Flow | $ -1.60M | $ -69.67M | $ -33.53M | $ -18.72M | $ 10.44M |
| Investing Cash Flow | $ 18.13M | $ -22.16M | $ -17.39M | $ -36.72M | $ -15.52M |
| Financing Cash Flow | $ 12.06M | $ 82.11M | $ 28.46M | $ 8.35M | $ 113.11M |